转导(生物物理学)
衣壳
向性
转基因
增强子
细胞生物学
体内
基因组工程
HEK 293细胞
生物
原电池
基因传递
结构母题
遗传增强
分子生物学
RGD基序
化学
Jurkat细胞
免疫疗法
全身给药
细胞培养
序列母题
基因组编辑
基因组
计算生物学
T细胞
体外
细胞
蛋白质工程
人类基因组
癌症研究
转座因子
逆转录病毒
基因
转染
病毒学
组织向性
作者
Lingjuan Hong,Gennong Chen,Yongjun Liu,Yuanfang Cao,Xueting Li,Weijie Li,Yumu Pan,Huahe Wang,Gaomeng Ru,Siyu Yang,Ming Cheng,Tongtong Lv,Yunfan Zhu,Shan Huang,Xiaoxiao Nian,Hongling Ou,Chengkun Wang,Sean X. Gu,Monkol Lek,Lupeng Ye
标识
DOI:10.1038/s41587-026-03344-5
摘要
Abstract Adeno-associated virus (AAV) vectors have been applied for precise genome engineering in human T cells but poor tropism restricts their efficiency and translational potential. Here, through directed evolution of the AAV6 capsid in primary human T cells, we identified a family of variants containing an APR motif at residues 455–457. The lead candidate, AAV.APR31, enabled robust transduction of primary T and NK cells at nearly 100–1,000-fold lower doses than AAV6 and outperformed the human T cell-tropic capsid AAV-hT7. CRISPR screening identified CD7 as a lineage-specific entry enhancer alongside the canonical AAVR pathway and structural analysis suggested that the APR motif facilitates CD7 engagement. Unlike existing delivery systems confined to one engineering mode, AAV.APR31 enabled transient transgene delivery, site-specific knock-in and transposon integration in human T and NK cells, generating CAR-T cells functionally equivalent to lentiviral vector-manufactured products. Systemic administration of AAV.APR31-generated CAR-T cells in vivo resulted in potent tumor control in hematologic and solid tumor mouse models.
科研通智能强力驱动
Strongly Powered by AbleSci AI